NCT02604654View on ClinicalTrials.gov

Effectiveness and Safety of Yiqitongluo Granule for Stroke

PHASE4CompletedINTERVENTIONAL
Enrollment

2,197

Participants

Timeline

Start Date

December 29, 2015

Primary Completion Date

November 5, 2017

Study Completion Date

December 6, 2017

Conditions
Stroke
Interventions
DRUG

Yiqitongluo granule

administered after dissolved

All Listed Sponsors
collaborator

Shineway Pharmaceutical Co.,Ltd

INDUSTRY

lead

Yi Yang

OTHER

NCT02604654 - Effectiveness and Safety of Yiqitongluo Granule for Stroke | Biotech Hunter | Biotech Hunter